Breast cancer circulating biomarkers: advantages, drawbacks, and new insights. - Wikidata - wikimedia - TriplyDB

Breast cancer circulating biomarkers: advantages, drawbacks, and new insights.

Breast cancer circulating biomarkers: advantages, drawbacks, and new insights.

http://www.wikidata.org/entity/Q38573871

about

Progress in the clinical detection of heterogeneity in breast cancer Detecting Blood-Based Biomarkers in Metastatic Breast Cancer: A Systematic Review of Their Current Status and Clinical Utility.Prognostic Impact of the Tumor Marker CA 15-3 in Patients With Breast Cancer and Bone Metastases Treated With Palliative Radiotherapy.A novel panel of serum miR-21/miR-155/miR-365 as a potential diagnostic biomarker for breast cancer.Periostin is identified as a putative metastatic marker in breast cancer-derived exosomes.Evidence on the cost of breast cancer drugs is required for rational decision making.Predicting the response to neoadjuvant therapy for early-stage breast cancer: tumor-, blood-, and imaging-related biomarkers Screen-printed Electrochemical Immunosensors for the Detection of Cancer and Cardiovascular Biomarkers

P2860

Q28079224-FDA0D217-1B16-461D-B95E-B39D9205292B Q30238465-B51914E5-76E9-49D1-AC92-4B6513576D08 Q37621222-8DA433FE-C87C-4876-AB55-479854BA4405 Q37641977-75602864-53F3-489F-82C0-01382C6E0329 Q37688879-3EA5840E-660B-4CA0-BBDB-996692D65645 Q55021818-8A393147-457B-4203-9736-F85FD5B162C0 Q57816466-C4152408-E90A-4247-9A41-2D4FFEB40265 Q59304235-FDE3093A-F596-42A9-9C53-CC2287622C5B

P2860

Breast cancer circulating biomarkers: advantages, drawbacks, and new insights.

http://www.wikidata.org/entity/Q38573871

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Breast cancer circulating biomarkers: advantages, drawbacks, and new insights.

@en

type

label

Breast cancer circulating biomarkers: advantages, drawbacks, and new insights.

@en

prefLabel

Breast cancer circulating biomarkers: advantages, drawbacks, and new insights.

@en

P1433

Q38573871-46277774-A8B2-4EB6-AB95-001D26746FDA

P1476

Q38573871-4C6834AA-B37F-496D-AB95-1FED7F5FA1AB

P2093

Q38573871-039DA09D-BBAA-42DF-9857-341CB7D2D20D

Q38573871-1A2A6AF2-D0A2-4837-9882-3BBF3F28B52B

Q38573871-3F3F4DA7-D5F6-487F-977C-B9905C044BA9

Q38573871-4A84D954-A609-45D3-99CD-3B113C9D4874

Q38573871-4E4E71AC-5465-41DD-B804-ED0B7A1A1631

Q38573871-50231039-273E-426C-ADA2-8A6E065B8E2F

Q38573871-51175108-B300-4C5A-8F01-6DFA9FA5E7CF

Q38573871-624DFFAC-FA89-48B5-9B00-4BD8F6E26E57

Q38573871-6953593C-A5C5-4285-988E-78F09E6A46CB

Q38573871-87A4B5F5-847F-466F-BB36-A149BA1C3534

P2860

Q38573871-01150E7E-640E-4E09-AF47-7255767E4D9E

Q38573871-04333119-3463-4114-A4AE-E158C09F9AEC

Q38573871-04404370-A888-4EF6-9B1B-AE39055C3869

Q38573871-04538E71-4189-4FDB-9F57-D63AD568AA3C

Q38573871-0D49860E-EFD3-47E4-8E31-9C3D626374A7

Q38573871-0FE3BC4E-5A07-4D71-B4B8-4D6D489C4812

Q38573871-105BC305-43C2-43A9-A5D7-E8D2622EC554

Q38573871-1428220B-B687-4243-A602-D03208542A33

Q38573871-1825C7C6-7850-4C40-9DCB-6ADE8C51D264

Q38573871-1A908BE8-5125-4FB1-9D02-49A7C54A3C4E

P2888

Q38573871-87EA23CB-3390-4CA4-9FFD-D500D516D8AA

P304

Q38573871-8F1792AE-328E-40F9-B1E0-750DE0B17F47

P31

Q38573871-5E7165E6-A545-4A83-8D86-54A22C376FB6

P356

Q38573871-A3C4A48E-62FE-4DA1-B307-6884AA9C1DFC

P433

Q38573871-9C77EEAA-1ACA-4C03-9909-61D03DCC55D0

P478

Q38573871-E513B24F-EDA5-4887-B247-3DDC80017D33

P50

Q38573871-89F5E943-7E2B-47BD-B855-36CF5C8620CD

Q38573871-B33A510C-00EE-4F0B-BBA7-E05A3D70B265

P577

Q38573871-9E1ECE17-CA89-4A2E-9DD7-EEE29730C14E

P5875

Q38573871-2734437C-326A-4C04-9072-FA349538F448

P6179

Q38573871-BDBB9A56-F794-499F-99F2-ADCB076E4AA1

P698

Q38573871-97E4F14C-8403-47EC-8603-E7944788F371

P921

Q38573871-98D9480A-C93C-436F-A7C1-6354EC058DD8

P356

S13277-015-3944-7

P1433

P1476

Breast cancer circulating biomarkers: advantages, drawbacks, and new insights

@en

P2093

Alberto Bottini

http://www.w3.org/2001/XMLSchema#string

Andrea Ravelli

http://www.w3.org/2001/XMLSchema#string

Angela Gobbi

http://www.w3.org/2001/XMLSchema#string

Chiara Senti

http://www.w3.org/2001/XMLSchema#string

Daniele Generali

http://www.w3.org/2001/XMLSchema#string

Daniele Spada

http://www.w3.org/2001/XMLSchema#string

Francesco Lanza

http://www.w3.org/2001/XMLSchema#string

James M Reuben

http://www.w3.org/2001/XMLSchema#string

Laura Zanotti

http://www.w3.org/2001/XMLSchema#string

Manuela Milani

http://www.w3.org/2001/XMLSchema#string

P2860

Expression of stem cell and epithelial-mesenchymal transition markers in circulating tumor cells of breast cancer patients

Cancer genome landscapes

Microvesicles: mediators of extracellular communication during cancer progression

Circulating microRNAs as noninvasive biomarkers in breast cancer

Cancer statistics, 2015

MicroRNA gene expression deregulation in human breast cancer

MicroRNAs: genomics, biogenesis, mechanism, and function

The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

Switching from repression to activation: microRNAs can up-regulate translation

P2888

s13277-015-3944-7

P304

6653-6665

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13277-015-3944-7

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

Massimo Martino

P577

2015-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281343487

http://www.w3.org/2001/XMLSchema#string

P6179

1002707107

http://www.w3.org/2001/XMLSchema#string

P698

26307395

http://www.w3.org/2001/XMLSchema#string

P921